Physician

Abid Aslam, M.D.

According to 2025 Medicare claims, Abid Aslam, M.D. (NPI: 1912223298) practices nephrology in the Abilene, TX market, with the plurality of this provider's patient population coming from Taylor, TX. This provider's primary affiliated billing organization is HENDRICK PROVIDER NETWORK (NPI: 1396961322; TIN: 752660403) and primary practice location at 79601-2432.

Aslam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 268 traditional Medicare patients, billed 1,278 HCPCS/CPT codes, and received $95,907 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 282 prescription claims across 99 beneficiaries totaling $9,795 in drug costs, led by Losartan Potassium (Losartan Potassium). 2022 DME data shows 25 claims. Open Payments data shows 2 records totaling $41. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $66,090 to $95,907. Similarly, Part D prescription costs have fallen sharply in recent years, from $53,938 to $9,795. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	251	1,419	$66,090
2016	624	9,178	$227,491
2017	757	19,807	$367,984
2018	751	23,029	$349,514
2019	732	14,124	$302,811
2020	727	13,905	$273,759
2021	566	9,434	$220,032
2022	464	8,119	$186,384
2023	355	5,316	$130,208
2024	268	1,278	$95,907

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	147	653	$53,938
2016	399	2,489	$206,835
2017	536	4,869	$603,007
2018	527	4,495	$387,909
2019	470	3,287	$213,766
2020	441	2,766	$105,525
2021	360	2,323	$107,960
2022	353	2,313	$123,748
2023	319	1,708	$83,711
2024	99	282	$9,795

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	51	$7,241
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	25	$407
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	112	115	$130
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	14	15	$100
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	121	275	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	193	743	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	18	24	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Losartan Potassium	Losartan Potassium	16	1,380	$306
Nifedipine Er	Nifedipine	12	540	$285
Torsemide	Torsemide	13	798	$197
Famotidine	Famotidine	11	984	$162
Tamsulosin Hcl	Tamsulosin Hcl	14	1,020	$117

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$41	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abid Aslam, M.D.?

Tedicare shows public-source Medicare data for Abid Aslam, M.D. (NPI 1912223298), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abid Aslam, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abid Aslam, M.D.?

Abid Aslam, M.D. is linked to HENDRICK PROVIDER NETWORK (billing NPI 1396961322) in the available physician profile data.

Does Abid Aslam, M.D. have Open Payments data?

Abid Aslam, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.